Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Fluorescence Imaging Agents Market: By Fluorophore Type, By Application, By Target Molecule, By Modality, Geography
Fluorescence Imaging Agents Market size was valued at US$ 2,182.4 million in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030. Fluorescence imaging agents, vital tools in medical research and diagnostics, are revolutionizing our understanding of biological processes. This market, fueled by continuous innovation and expanding applications, is experiencing significant growth. The fluorescence imaging agents market is experiencing a surge in growth, driven by a confluence of scientific advancements, evolving healthcare needs, and a growing emphasis on precision medicine. These agents, instrumental in medical research and diagnostics, utilize fluorescent molecules to visualize biological processes at the cellular and molecular level. In addition, the global population is aging, and the prevalence of chronic diseases like cancer, Alzheimer's, and cardiovascular diseases is rising. This creates a greater need for accurate and efficient diagnostic tools. Fluorescence imaging agents can help detect diseases at early stages when they are most treatable, improving patient outcomes and prognosis. These agents can be used to guide surgeons during minimally invasive procedures, leading to improved precision and reduced complications. Also, fluorescence imaging allows for the development of treatment plans tailored to a patient's specific disease characteristics.
Furthermore, the global research base is expanding rapidly, fueled by increased funding and a growing focus on life sciences. Fluorescence imaging agents play a vital role in various research applications, including drug discovery and development, understanding cellular processes, and gene expression analysis. These agents help researchers visualize the distribution, efficacy, and potential side effects of new drug candidates in animal models. Moreover, fluorescence imaging allows researchers to study complex cellular processes in real-time, leading to a deeper understanding of diseases and their progression. Furthermore, specific imaging agents can be used to visualize the expression of specific genes within cells, providing valuable insights into gene function and regulation. However, developing and validating new fluorescence imaging agents can be expensive due to stringent regulatory requirements and complex production processes.
Study Period
2024-2030Base Year
2023CAGR
6.1%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing focus on personalized medicine and early disease detection is driving the demand for advanced diagnostic tools. Fluorescence imaging agents offer several advantages over traditional diagnostic methods such as high sensitivity and specificity, real-time visualization, and non-invasive or minimally invasive techniques. In addition, continuous research and development are leading to significant advancements in fluorescence imaging technologies, further propelling the market for imaging agents. Researchers are developing brighter, more photostable, and biocompatible fluorophores, expanding the range of applications and improving image quality. Also, fluorescence imaging agents are being designed for compatibility with other imaging modalities like PET (positron emission tomography) or MRI (magnetic resonance imaging), providing a more comprehensive view of biological processes. Moreover, the development of targeted delivery systems allows for specific delivery of imaging agents to their target sites within the body, minimizing background noise and enhancing signal-to-noise ratio.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2,182.4 million |
Market CAGR |
6.1% |
By Fluorophore Type |
|
By Application |
|
By Target Molecule |
|
By Modality |
|
Download Free Sample Report
The Asia Pacific is the fastest growing region in the fluorescence imaging agents market.
The North American region is dominating the fluorescence imaging agents market.
The leading players in the Fluorescence Imaging Agents Market are Samsung Medical Centre, Amgen, Novartis Pharmaceuticals, Astellas Pharma Global Development, Inc., Hoffmann-La Roche, Quest Medical Imaging B.V., Stryker, KARL STORZ SE & Co. KG, Olympus, Hamamatsu Photonics K.K, Mizuho Medical Co, Ltd., Shimadzu Corporation, Leica Microsystems, Medtronic (Visionsense), PerkinElmer, Inc., Carl Zeiss Meditec, and Fluoptics.
Historic years considered for the market study are 2019 to 2022, 2023 is considered as the base year for market estimation and the forecast presented from 2024 to 2030.
1.Executive Summary |
2.Global Fluorescence Imaging Agents Market Introduction |
2.1.Global Fluorescence Imaging Agents Market - Taxonomy |
2.2.Global Fluorescence Imaging Agents Market - Definitions |
2.2.1.Fluorophore Type |
2.2.2.Application |
2.2.3.Target Molecule |
2.2.4.Modality |
2.2.5.Region |
3.Global Fluorescence Imaging Agents Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Fluorescence Imaging Agents Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Fluorescence Imaging Agents Market By Fluorophore Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Organic Fluorophores |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Semiconductor Nanocrystals |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Lanthanide Based Probes |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Fluorescence Imaging Agents Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Preclinical Imaging |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Intraoperative Imaging |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. In Vivo Imaging |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. In-Vitro Diagnostics |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Fluorescence Imaging Agents Market By Target Molecule, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Antibodies & Antibody Fragments |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Small Molecule Probes |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Nucleic Acid Dyes |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Fluorescence Imaging Agents Market By Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Optical Imaging |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Multimodal Imaging |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9.Global Fluorescence Imaging Agents Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Fluorescence Imaging Agents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Fluorophore Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Organic Fluorophores |
10.1.2.Semiconductor Nanocrystals |
10.1.3.Lanthanide Based Probes |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Preclinical Imaging |
10.2.2.Intraoperative Imaging |
10.2.3.In Vivo Imaging |
10.2.4.In-Vitro Diagnostics |
10.3. Target Molecule Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Antibodies & Antibody Fragments |
10.3.2.Small Molecule Probes |
10.3.3.Nucleic Acid Dyes |
10.4. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Optical Imaging |
10.4.2.Multimodal Imaging |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Fluorescence Imaging Agents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Fluorophore Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Organic Fluorophores |
11.1.2.Semiconductor Nanocrystals |
11.1.3.Lanthanide Based Probes |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Preclinical Imaging |
11.2.2.Intraoperative Imaging |
11.2.3.In Vivo Imaging |
11.2.4.In-Vitro Diagnostics |
11.3. Target Molecule Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Antibodies & Antibody Fragments |
11.3.2.Small Molecule Probes |
11.3.3.Nucleic Acid Dyes |
11.4. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Optical Imaging |
11.4.2.Multimodal Imaging |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Fluorescence Imaging Agents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Fluorophore Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Organic Fluorophores |
12.1.2.Semiconductor Nanocrystals |
12.1.3.Lanthanide Based Probes |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Preclinical Imaging |
12.2.2.Intraoperative Imaging |
12.2.3.In Vivo Imaging |
12.2.4.In-Vitro Diagnostics |
12.3. Target Molecule Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Antibodies & Antibody Fragments |
12.3.2.Small Molecule Probes |
12.3.3.Nucleic Acid Dyes |
12.4. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Optical Imaging |
12.4.2.Multimodal Imaging |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Fluorescence Imaging Agents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Fluorophore Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Organic Fluorophores |
13.1.2.Semiconductor Nanocrystals |
13.1.3.Lanthanide Based Probes |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Preclinical Imaging |
13.2.2.Intraoperative Imaging |
13.2.3.In Vivo Imaging |
13.2.4.In-Vitro Diagnostics |
13.3. Target Molecule Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Antibodies & Antibody Fragments |
13.3.2.Small Molecule Probes |
13.3.3.Nucleic Acid Dyes |
13.4. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Optical Imaging |
13.4.2.Multimodal Imaging |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Fluorescence Imaging Agents Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Fluorophore Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Organic Fluorophores |
14.1.2.Semiconductor Nanocrystals |
14.1.3.Lanthanide Based Probes |
14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Preclinical Imaging |
14.2.2.Intraoperative Imaging |
14.2.3.In Vivo Imaging |
14.2.4.In-Vitro Diagnostics |
14.3. Target Molecule Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Antibodies & Antibody Fragments |
14.3.2.Small Molecule Probes |
14.3.3.Nucleic Acid Dyes |
14.4. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Optical Imaging |
14.4.2.Multimodal Imaging |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Samsung Medical Centre |
15.2.2.Amgen |
15.2.3.Novartis Pharmaceuticals |
15.2.4.Astellas Pharma Global Development, Inc. |
15.2.5.Hoffmann-La Roche |
15.2.6.Quest Medical Imaging B.V. |
15.2.7.Stryker |
15.2.8.KARL STORZ SE & Co. KG |
15.2.9.Olympus |
15.2.10.Hamamatsu Photonics K.K |
15.2.11.Mizuho Medical Co, Ltd. |
15.2.12.Shimadzu Corporation |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players